Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...
In June 2021, Kenneth A. Bauer, MD, from Beth Israel Deaconess Medical Center and professor of medicine at Harvard Medical School, spoke with Healio about the diagnosis and treatment of hereditary ...
Hereditary antithrombin (AT) deficiency — an autosomal dominant disorder caused by SERPINC1 gene mutations — carries a high risk of venous thromboembolism. Treatment requires the long-term use of oral ...